Luye Pharma Group Ltd. (LYPHF)
Market Closed
17 Jul, 20:00
$
0. 27
-0.05
-14.7996%
$
1.31B Market Cap
- P/E Ratio
- Div Yield
2,500 Volume
- Eps
$ 0.32
Previous Close Want to track LYPHF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Luye Pharma Group Ltd. (LYPHF) Statistics
Valuation metrics
Market Cap 1.31B
Enterprise value 12.02B
Trailing P/E (ttm) 11.18
Forward P/E -
PEG ratio 0.34
Price/Sales (ttm) 1.13
Price/Book (mrq) 0.45
Enterprise Value/Revenue 1.91
Enterprise Value/EBITDA 6.38
Overview
Shares outstanding 3.99B
Float 2.2B
Shares short -
% Held by insiders 0.31%
% Held by institutions 0.27%
Average volume (10 days) 101.88K
Average volume (90 days) 77.07K
Price summary
52-Week low 0.2
52-Week high 0.4
Beta 0.92
50-Day moving average 0.25
200-Day moving average 0.34
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 30 Jun 2012
Profitability
Profit margin 0.1%
Operating margin 0.2%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.04%
Income Statement
Revenue (ttm) 928.28M
Revenue per share (ttm) 1.56
Quarterly revenue growth (yoy) 0.05%
Gross profit (ttm) 612.52M
EBITDA 336.59M
Net income to common (ttm) 91.05M
Diluted EPS (ttm) 0.15
Quarterly earnings growth (yoy) 2.64%
Balance Sheet
Total cash (mrq) 1.1B
Total cash per share (mrq) 2.2
Total debt (mrq) 1.52B
Total Debt/Equity (mrq) 0.59
Current ratio (mrq) 1.53%
Book value per share (mrq) 4.63
Cash Flow
Cash flow statement 262.39M
Levered free cash flow (LFCF) -101.95M
